The process development and the kilogram-scale synthesis of BMS-688521 (1) are described. The synthesis features a highly efficient telescoped sequence which utilizes previously described spirocyclic hydantoin (4b) to produce the final intermediate via an SNAR reaction. A final deprotection step affords BMS-688521 (1) in high quality with an overall yield of 65% from the key intermediate, spirocyclic hydantoin (4b).
No takes yet. Share an insight, caveat, or question.
DelMonte et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: